News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GILLIS STEVEN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/27/2021 |
3
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 3 on DA32 Life Science Tech Acquisition Corp. |
| 07/15/2021 |
3
| ARCH Venture Partners X, LLC (10% Owner) has filed a Form 3 on Erasca, Inc. |
| 06/16/2021 |
3
| ARCH Venture Fund X, L.P. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 02/03/2021 |
3
| ARCH Venture Fund X, L.P. (10% Owner) has filed a Form 3 on Sana Biotechnology, Inc. |
| 10/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/27/2018 |
3
| GILLIS STEVEN (Director) has filed a Form 3 on Homology Medicines, Inc. |
| 03/31/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/17/2016 |
3
| GILLIS STEVEN (10% Owner) has filed a Form 3 on PHASERX, INC. |
| 06/18/2013 |
3
| GILLIS STEVEN (Director) has filed a Form 3 on bluebird bio, Inc. |
|
|